All In Biotech

Drug Trial Radar · NCT04683848

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Last checked: Nov 20, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Aug 27, 2021

Primary completion

Dec 24, 2024

Study completion Apr 9, 2025

Sponsor

Lead sponsor
Tanabe Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Dec 24, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic cervical spinal cord injury. Subjects meeting eligibility criteria will enter the 6-month double-blind period. Subjects will be randomized in a 2:1 ratio to receive MT-3921 or placebo in a double blind manner.

Conditions

  • Spinal Cord Injury

Interventions

  • MT-3921Biological

    Solution for infusion; Intravenous (IV)

  • PlaceboBiological

    Solution for infusion; Intravenous (IV)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Upper Extremity Motor Score (UEMS)Time frame: Baseline and at Day 180

Locations

23 sites in 3 countries. Site status is shown where the registry gives one.

  • University of California Irvine

    Orange, California

  • Tallahassee Neurological Clinic

    Tallahassee, Florida

  • Augusta University

    Augusta, Georgia

  • University of Kentucky

    Lexington, Kentucky

  • Spectrum Health

    Grand Rapids, Michigan

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Saint Louis University Hospital

    St Louis, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Carolinas Rehabilitation

    Charlotte, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Oregon Health and Science University - Center for Health & Healing

    Portland, Oregon

  • Brooke Army Medical Center in San Antonio

    Houston, Texas

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas

  • Carilion Clinic

    Roanoke, Virginia

  • Medical College of Wisconsin - Froedtert Hospital

    Milwaukee, Wisconsin

  • NSHA-Queen Elizabeth II Health Sciences Centre

    Halifax, Nova Scotia, Canada

  • The Ottawa Hospital

    Ottawa, Ontario, Canada

  • Japan Organization of Occupational Health and Safety SPINAL INJURIES CENTER

    Izuka-shi, Fukuoka, Japan

  • Gifu University Hospital

    Gifu, Gifu, Japan

  • Hokkaido Spinal Cord Injury Center

    Bibai-shi, Hokkaido, Japan

  • Japanese Red Cross Kobe Hospital

    Kobe, Hyōgo, Japan

  • National Hospital Organization Kumamoto Medical Center

    Kumamoto, Kumamoto, Japan

  • Murayama Medical Center

    Musashimurayama-shi, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.